These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11928379)

  • 21. Tuberculous peritonitis during infliximab therapy.
    Verhave JC; van Altena R; Wijnands MJ; Roerdink HT
    Neth J Med; 2008 Feb; 66(2):77-80. PubMed ID: 18292611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficiency of switching from infliximab to etanercept and vice-versa in patients with rheumatoid arthritis.
    Cohen G; Courvoisier N; Cohen JD; Zaltni S; Sany J; Combe B
    Clin Exp Rheumatol; 2005; 23(6):795-800. PubMed ID: 16396697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tuberculosis under anti-TNF therapy: case series of a center (reporting the experience from the period 2006-2019).
    Valido A; Dinis JS; Saavedra MJ; Fonseca JE
    Acta Reumatol Port; 2020; 45(4):281-287. PubMed ID: 33423034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of active tuberculosis in patients with inflammatory arthritis receiving TNF inhibitors: a look beyond the baseline tuberculosis screening protocol.
    Soare A; Gheorghiu AM; Aramă V; Bumbăcea D; Dobrotă R; Oneaţă R; Pintilie S; Milicescu M; Ancuţa I; Martin A; Sasu M; Ciofu C; Macovei L; Stoica V; Bojincă M; Mihai C
    Clin Rheumatol; 2018 Sep; 37(9):2391-2397. PubMed ID: 29150737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.
    Gómez-Reino JJ; Carmona L; Valverde VR; Mola EM; Montero MD;
    Arthritis Rheum; 2003 Aug; 48(8):2122-7. PubMed ID: 12905464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pulmonary tuberculosis associated to adalimumab: a study of 3 cases].
    Blanco Pérez JJ; Aranda Torres A; Pego Reigosa JM; Núñez Delgado M; Temes Montes E; Guerra Vales JL
    Arch Bronconeumol; 2010 Apr; 46(4):203-5. PubMed ID: 19896259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infliximab and brucellosis: not the usual suspects, this time.
    Akgul O; Ozgocmen S
    Mod Rheumatol; 2011 Jun; 21(3):313-5. PubMed ID: 21243400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition.
    Vassallo R; Matteson E; Thomas CF
    Chest; 2002 Sep; 122(3):1093-6. PubMed ID: 12226061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
    JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Worsening of subacute lupus erythematosus induced by infliximab].
    Vabre-Latre CM; Bayle P; Marguery MC; Gadroy A; Durand D; Bazex J
    Ann Dermatol Venereol; 2005 Apr; 132(4):349-53. PubMed ID: 15886563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidrug resistant miliary tuberculosis during infliximab therapy despite tuberculosis screening.
    Gin A; Dolianitis C
    Australas J Dermatol; 2014 May; 55(2):140-1. PubMed ID: 23713793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha-neutralizing antibody: a possible healthcare-associated case?
    De Rosa FG; Shaz D; Campagna AC; Dellaripa PE; Khettry U; Craven DE
    Infect Control Hosp Epidemiol; 2003 Jul; 24(7):477-82. PubMed ID: 12887234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disseminated tuberculosis after anti-TNFalpha treatment.
    Malipeddi AS; Rajendran R; Kallarackal G
    Lancet; 2007 Jan; 369(9556):162. PubMed ID: 17223480
    [No Abstract]   [Full Text] [Related]  

  • 34. [Disseminated tuberculosis following infliximab therapy for Crohn disease: a case report].
    Bouchentouf R; Yasser Z; Aitbenasser MA
    Rev Pneumol Clin; 2014 Dec; 70(6):366-9. PubMed ID: 25131370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary infectious complications associated with anti-TNFalpha therapy (infliximab) for rheumatoid arthritis.
    Imaizumi K; Sugishita M; Usui M; Kawabe T; Hashimoto N; Hasegawa Y
    Intern Med; 2006; 45(10):685-8. PubMed ID: 16778341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Meta analysis of infection risks of anti-TNF-α treatment in rheumatoid arthritis].
    Xie X; Chen J; Peng Y; Gao J; Tian J; Ling G; Du J; Mao N; Wu P; Li F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 38(7):722-36. PubMed ID: 23908082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exacerbation of tuberculosis enteritis after treatment with infliximab.
    Liberopoulos EN; Drosos AA; Elisaf MS
    Am J Med; 2002 Nov; 113(7):615. PubMed ID: 12459414
    [No Abstract]   [Full Text] [Related]  

  • 38. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.
    Keane J; Gershon S; Wise RP; Mirabile-Levens E; Kasznica J; Schwieterman WD; Siegel JN; Braun MM
    N Engl J Med; 2001 Oct; 345(15):1098-104. PubMed ID: 11596589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with infliximab.
    Fabre S; Gibert C; Lechiche C; Dereure J; Jorgensen C; Sany J
    Clin Exp Rheumatol; 2005; 23(6):891-2. PubMed ID: 16396712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fibrosing alveolitis after treatement of rheumatoid arthritis by infliximab].
    Nouijai A; Mounach A; Ghozlani I; Achemlal L; Bezza A; El Maghraoui A
    Presse Med; 2009 Oct; 38(10):e17-20. PubMed ID: 19447578
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.